Riordan T (2007) Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin Microbiol Rev 20(4):622–659
Article CAS PubMed PubMed Central Google Scholar
Henry S, DeMaria A Jr., McCabe WR (1983) Bacteremia due to Fusobacterium species. Am J Med 75(2):225–231
Article CAS PubMed Google Scholar
Citron DM (2002) Update on the taxonomy and clinical aspects of the genus fusobacterium. Clin Infect Dis 35(Suppl 1):S22–S27
Jang SS, Hirsh DC (1994) Characterization, distribution, and microbiological associations of Fusobacterium spp. in clinical specimens of animal origin. J Clin Microbiol 32(2):384–387
Article CAS PubMed PubMed Central Google Scholar
Centor RM et al (2015) The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 162(4):241–247
Brazier JS et al (2002) Fusobacterium necrophorum infections in England and Wales 1990–2000. J Med Microbiol 51(3):269–272
Article CAS PubMed Google Scholar
Brazier JS (2006) Human infections with Fusobacterium necrophorum. Anaerobe 12(4):165–172
Fujiwara N et al (2020) Involvement of Fusobacterium species in oral Cancer progression: a Literature Review Including other types of Cancer. Int J Mol Sci, 21(17)
Mitsuhashi K et al (2015) Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6(9):7209–7220
Article PubMed PubMed Central Google Scholar
McCoy AN et al (2013) Fusobacterium is associated with colorectal adenomas. PLoS ONE 8(1):e53653
Article CAS PubMed PubMed Central Google Scholar
Swidsinski A et al (2011) Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60(1):34–40
Strauss J et al (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978
Leal J et al (2010) Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol 31(7):740–747
Friedman ND et al (2002) Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797
Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
Article CAS PubMed Google Scholar
Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130–1139
Queensland Population Projects (2002) to 2026. 22 September 2021]; https://public.tableau.com/views/HHSpopulationprojections
Laupland KB et al (2018) Culturing rate and the surveillance of bloodstream infections: a population-based assessment. Clin Microbiol Infect 24(8):910e1–910e4
Almohaya AM et al (2020) Fusobacterium bloodstream infections: a literature review and hospital-based case series. Anaerobe 62:102165
Article CAS PubMed Google Scholar
King M et al (2020) The link between Fusobacteria and Colon cancer: a fulminant example and review of the evidence. Immune Netw 20(4):e30
Article PubMed PubMed Central Google Scholar
Alon-Maimon T, Mandelboim O, Bachrach G (2022) Fusobacterium nucleatum and cancer. Periodontol 2000 89(1):166–180
Article PubMed PubMed Central Google Scholar
Legaria MC et al (2005) Clindamycin-resistant Fusobacterium varium bacteremia and decubitus ulcer infection. J Clin Microbiol 43(8):4293–4295
Article CAS PubMed PubMed Central Google Scholar
Vidaurrazaga MM, McKinley GF, Camins BC (2020) Postpartum Fusobacterium gonidiaformans bacteremia. Anaerobe 62:102168
Garcia-Carretero R et al (2017) Clinical features and outcomes of Fusobacterium species infections in a ten-year follow-up. J Crit Care Med (Targu Mures) 3(4):141–147
Pett E, Saeed K, Dryden M (2014) Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital. Infection 42(2):363–370
Article CAS PubMed Google Scholar
Yang CC et al (2011) Characteristics and outcomes of Fusobacterium nucleatum bacteremia–a 6-year experience at a tertiary care hospital in northern Taiwan. Diagn Microbiol Infect Dis 70(2):167–174
Yusuf E, Wybo I, Piérard D (2016) Case series of patients with Fusobacterium nucleatum bacteremia with emphasis on the presence of cancer. Anaerobe 39:1–3
Bourgault AM et al (1997) Fusobacterium bacteremia: clinical experience with 40 cases. Clin Infect Dis 25(Suppl 2):S181–S183
Afra K et al (2013) Incidence, risk factors, and outcomes of Fusobacterium species bacteremia. BMC Infect Dis 13:264
Article PubMed PubMed Central Google Scholar
Su CP et al (2009) Fusobacterium bacteremia: clinical significance and outcomes. J Microbiol Immunol Infect 42(4):336–342
Candoni A et al (2003) Fusobacterium nucleatum: a rare cause of bacteremia in neutropenic patients with leukemia and lymphoma. Clin Microbiol Infect 9(11):1112–1115
Article CAS PubMed Google Scholar
Fanourgiakis P et al (2003) Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Support Care Cancer 11(5):332–335
Article CAS PubMed Google Scholar
Seibel J et al (2020) Fusobacterium nucleatum bacteremia with pneumopathy in a patient receiving eculizumab: a case report. Anaerobe 61:102099
Article CAS PubMed Google Scholar
Wolff L et al (2021) COVID-19-Associated Fusobacterium nucleatum Bacteremia, Belgium. Emerg Infect Dis 27(3):975–977
Article CAS PubMed PubMed Central Google Scholar
Aldridge KE et al (2001) Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother 45(4):1238–1243
Article CAS PubMed PubMed Central Google Scholar
Könönen E et al (1999) beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. Antimicrob Agents Chemother 43(5):1270–1273
留言 (0)